BCM
BML Capital Management Portfolio holdings
AUM
$113M
1-Year Est. Return
37.44%
This Fund
S&P 500
1 Year Est. Return
+37.44%
AUM
$109M
AUM Growth
-$21.8M
(-17%)
Holding
28
Top Buys
| 1 | +$2.81M | |
| 2 | +$985K | |
| 3 | +$404K | |
| 4 |
Arvinas
ARVN
|
+$379K |
| 5 |
Kezar Life Sciences
KZR
|
+$351K |
Top Sells
| 1 | +$7.18M | |
| 2 | +$2.2M | |
| 3 | +$2.16M | |
| 4 |
IMA
ImageneBio Inc
IMA
|
+$2.03M |
| 5 |
CNTB
Connect Biopharma Holdings
CNTB
|
+$981K |
Sector Composition
| 1 | Healthcare | 98.18% |
| 2 | Technology | 0.99% |
| 3 | Consumer Staples | 0.83% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Milestone Pharmaceuticals
MIST
$121M
| – | – |
-1,136,091
|
|
||
|
THRD
27
DELISTED
Third Harmonic Bio
THRD
| $0 | ﹤0.01% |
3,824,417
|
|
||
28
Walmart Inc
WMT
$990B
| – | – |
0
|
|